Trial record 1 of 1 for:    Io Therapeutics [Lead]
Previous Study | Return to List | Next Study

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Io Therapeutics.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Io Therapeutics
ClinicalTrials.gov Identifier:
NCT01540071
First received: November 13, 2011
Last updated: February 22, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)